anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.01.16 | Novartis kaufen | UBS AG | |
| 08.01.16 | Novartis Hold | Deutsche Bank AG | |
| 07.01.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 07.01.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.01.16 | Roche overweight | JP Morgan Chase & Co. | |
| 14.12.15 | Roche overweight | JP Morgan Chase & Co. | |
| 07.12.15 | Roche buy | Jefferies & Company Inc. | |
| 07.12.15 | Novartis buy | Jefferies & Company Inc. | |
| 04.12.15 | Roche buy | Goldman Sachs Group Inc. | |
| 03.12.15 | Roche overweight | JP Morgan Chase & Co. | |
| 02.12.15 | Roche buy | Citigroup Corp. | |
| 02.12.15 | Novartis buy | Citigroup Corp. | |
| 02.12.15 | Novartis Equal-Weight | Morgan Stanley | |
| 02.12.15 | Roche overweight | Morgan Stanley | |
| 30.11.15 | Novartis Hold | Deutsche Bank AG | |
| 30.11.15 | Roche buy | Deutsche Bank AG | |
| 25.11.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 25.11.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.11.15 | Roche overweight | Morgan Stanley | |
| 11.11.15 | Novartis neutral | Morgan Stanley | |
| 06.11.15 | Roche overweight | Morgan Stanley | |
| 06.11.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.11.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.11.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.15 | Roche buy | Deutsche Bank AG | |
| 28.10.15 | Novartis Halten | Independent Research GmbH | |
| 28.10.15 | Novartis Outperform | Bernstein Research | |
| 28.10.15 | Novartis buy | Kepler Cheuvreux | |
| 28.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis Hold | Deutsche Bank AG | |
| 28.10.15 | Novartis Equal weight | Barclays Capital | |
| 28.10.15 | Roche buy | UBS AG | |
| 28.10.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 27.10.15 | Novartis Hold | S&P Capital IQ | |
| 26.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.10.15 | Roche overweight | JP Morgan Chase & Co. | |
| 23.10.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.10.15 | Roche buy | Kepler Cheuvreux | |
| 22.10.15 | Novartis Outperform | BNP PARIBAS |
